We are excited to share that the updated ANSI/AAMI ST58:2024 standard has officially recognized chlorine dioxide foam as a high-level disinfectant for medical devices. This revision aligns with global guidelines and acknowledges chlorine dioxide as an effective solution for infection prevention in healthcare settings.
As part of this update, Tristel ULT, an innovative chlorine dioxide foam system for ultrasound probe disinfection, is highlighted for its efficiency, ease of use, and cost-effectiveness. With FDA De Novo clearance, Tristel ULT provides a rapid and reliable alternative to traditional high-level disinfection methods.
Read more here: Tristel ULT in ANSI-AAMI Press Release
Related Articles
Chlorine Dioxide Mode of Action on Viruses
Chlorine dioxide (ClO2) is a powerful biocide with proven efficacy against a wide range of microorganisms including viruses. Scientific research has been undertaken to understand the virucidal activity and mode […]
Learn more
Parker Labs partners with Tristel to deliver ultrasound disinfectant for U.S. market
Unique chlorine dioxide foam offers fast, efficient, and economical disinfection for ultrasound transducers. Parker Laboratories Inc. has entered a commercial partnership with UK-based infection prevention company Tristel to manufacture and […]
Learn more
Tristel ULT is approved by the FDA!
The wait is over…Tristel ULT is approved by the FDA! We are pleased to announce the US Food and Drug Administration (FDA) approval of our unique and market-leading high level […]
Learn more